The Helix Blog
The Helix Blog gives voice to City of Hope graduate students and their research.
New Genome-editing Platform Poised to Fuel the Next Generation of Genetic Medicines
July 16, 2018 | Zen Vuong
A novel gene-editing tool discovered at City of Hope has the potential to treat a variety of genetic diseases.
City of Hope Awarded $3.7 million to Develop Glioblastoma Clinical Trial
June 29, 2018 | Letisia Marquez
California Institute for Regenerative Medicine has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients, which would genetically alter blood stem cells to better tolerate chemotherapy.
Researcher's Ovarian Cancer Discovery Takes on Special Meaning
June 27, 2018 | City of Hope
The results of a study published earlier this year by TGen researchers (City of Hope affiliate) in the journal Clinical Cancer Research suggest an existing leukemia drug, ponatinib, shows promise against SCCOHT.
New handheld heart monitor is a breakthrough for childhood cancer survivors
June 22, 2018 | Maxine Nunes
A new electronic monitor called Vivio, developed by Caltech with City of Hope, promises to make cardiac screening easier and more accessible for cancer patients and physicians.
City of Hope Guides ASCO’s New Geriatric Cancer Recommendations
June 8, 2018 | Saundra Young
City of Hope physicians Arti Hurria, M.D., a geriatric oncologist, and William Dale, M.D., Ph.D., a geriatrician and palliative care physician, co-chaired the panel that developed the new ASCO guidelines designed to help doctors assess and manage care for older adults.
City of Hope Researchers Publish First Report on a Protein Inhibitor for Advanced Bladder Cancer
June 8, 2018 | Letisia Marquez
Advanced bladder cancer is particularly difficult to treat. The five-year survival rate for Stage 4 bladder cancer is only about 15 percent. Now, City of Hope researchers have discovered a that a novel drug blocks a key protein that drives the disease.
Researchers Discover Breakthrough Treatment For Advanced Squamous Cell Carcinoma
June 7, 2018 | Maxine Nunes
A couple of years ago, Timothy Satterfield, a retired chef, noticed a tiny mole on his forehead. He was referred to City of Hope, where a breakthrough immunotherapy trial is proving to be a game changer.
Load MoreBack To Top